MIR8073

Across TCGA pan-cancer cohorts, MIR8073 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR8073 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher MIR8073 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR8073 expression acts as an unfavorable survival marker.

MESO, UCS, and BLCA are the cancer types where MIR8073 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	II,III,IV	0.100	0.579	<.001	90	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	90	view →
BLCA	DFS	Tertile	All	0.263	0.632	<.001	54	view →
ACC	OS	Tertile	All	0.214	0.802	.002	45	view →
LGG	DFS	Tertile	All	0.401	0.765	.001	27	view →
HNSC	DFS	Tertile	II,III,IV	0.194	0.661	.031	18	view →
SKCM	OS	Tertile	III,IV	0.339	0.729	.019	9	view →
STAD	OS	Tertile	III,IV	0.325	0.542	.044	9	view →
KIRP	OS	Tertile	II,III,IV	0.184	0.743	.033	9	view →
SARC	DFS	Tertile	All	0.158	0.354	.040	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR8073–MESO (OS)

Open the MESO breakdown →